Submission of Revised BE Study Protocol: CDSCO Group Advises Laurus Labs on Carglumic Acid Dispersible Tablets.

Published Date: 27 Mar 2023

NEW DELHI: Pharmaceutical company Laurus Lab's proposal for clinical trial exemption of Carglumic Acid Dispersible Tablet 200mg rejected, Academic Committee...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Does pollution cause cancer?

2.

AI is equally capable of reading breast cancer scans as human radiologists.

3.

EVP Beats Cisplatin for Resectable MIBC

4.

New research points out a promising strategy for treating metastatic medulloblastoma

5.

Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot